Aarey Drugs & Pharmaceuticals Limited

BSE:524412 Stock Report

Market Cap: ₹1.7b

Aarey Drugs & Pharmaceuticals Management

Management criteria checks 4/4

Aarey Drugs & Pharmaceuticals' CEO is Mihir Ghatalia, appointed in Dec 2009, has a tenure of 20.33 years. total yearly compensation is ₹1.06M, comprised of 56.9% salary and 43.1% bonuses, including company stock and options. directly owns 16.49% of the company’s shares, worth ₹274.66M. The average tenure of the management team and the board of directors is 4.9 years and 4.7 years respectively.

Key information

Mihir Ghatalia

Chief executive officer

₹1.1m

Total compensation

CEO salary percentage56.9%
CEO tenure15yrs
CEO ownership16.5%
Management average tenure4.9yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mihir Ghatalia's remuneration changed compared to Aarey Drugs & Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹60m

Jun 30 2024n/an/a

₹52m

Mar 31 2024₹1m₹600k

₹47m

Dec 31 2023n/an/a

₹29m

Sep 30 2023n/an/a

₹24m

Jun 30 2023n/an/a

₹37m

Mar 31 2023₹1m₹600k

₹38m

Dec 31 2022n/an/a

₹27m

Sep 30 2022n/an/a

₹41m

Jun 30 2022n/an/a

₹48m

Mar 31 2022₹2m₹600k

₹66m

Dec 31 2021n/an/a

₹87m

Sep 30 2021n/an/a

₹85m

Jun 30 2021n/an/a

₹77m

Mar 31 2021₹1m₹602k

₹65m

Dec 31 2020n/an/a

₹61m

Sep 30 2020n/an/a

₹58m

Jun 30 2020n/an/a

₹51m

Mar 31 2020₹1m₹600k

₹58m

Dec 31 2019n/an/a

₹55m

Sep 30 2019n/an/a

₹57m

Jun 30 2019n/an/a

₹65m

Mar 31 2019₹2m₹600k

₹65m

Dec 31 2018n/an/a

₹66m

Sep 30 2018n/an/a

₹69m

Jun 30 2018n/an/a

₹64m

Mar 31 2018₹300k₹300k

₹62m

Compensation vs Market: Mihir's total compensation ($USD12.42K) is below average for companies of similar size in the Indian market ($USD42.34K).

Compensation vs Earnings: Mihir's compensation has been consistent with company performance over the past year.

CEO

Mihir Ghatalia (41 yo)

15yrs

Tenure

₹1,055,262

Compensation

Mr. Mihir Rajesh Ghatalia, B.E., serves as an Executive Director at Worth Investment & Trading Company Limited. He has been the Managing Director at Aarey Drugs & Pharmaceuticals Ltd. since December 29, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Mihir Ghatalia
Chairman & MD15yrs₹1.06m16.49%
₹ 274.7m
Nimit Ghatalia
Executive Director4.4yrs₹758.07kno data
Mira Ghatalia
Chief Financial Officer3.9yrsno datano data
A. Kathawala
Chief Accountant26.9yrsno datano data
Preeti Rathi
Company Secretary & Compliance Officer4.9yrs₹429.23kno data

4.9yrs

Average Tenure

41yo

Average Age

Experienced Management: 524412's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mihir Ghatalia
Chairman & MD20.3yrs₹1.06m16.49%
₹ 274.7m
Nimit Ghatalia
Executive Director4.4yrs₹758.07kno data
Lalit Tulsiani
Non-Executive Independent Director4.9yrsno data0.0030%
₹ 49.3k
Bina Ghatalia
Non Independent Non-Executive Woman Director1.2yrsno data14.12%
₹ 235.2m
Chetan Kiritbhai Mehta
Non-Executive Independent Director16.5yrsno data1.06%
₹ 17.6m
Anil Mandal
Independent Non Executive Director4.4yrsno datano data

4.7yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 524412's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 16:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aarey Drugs & Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research